ZBiotics

San Francisco, CA · Founded 2016 · Privately Held (backing)

Developer of genetically engineered probiotics designed to improve the body's ability to break down unwanted byproducts of alcohol to convert sugar into fiber in the gut. ZBiotics is based in San Francisco, CA and was founded in 2016. It was valued at $67 million at its later-stage round in Aug 2024, the last priced event on record. It has raised $40.3 million across 2 recorded rounds; the latest was a $22.4 million early-stage round in Mar 2024.

PMV mark · valuation
$67.0M
Oct 2026
Priced at
its later-stage round
Aug 2024
Total raised
$40.3M
Last round
Early Stage VC
Mar 2024
What is ZBiotics worth?
$67.0MPrivateMarketView mark · Oct 2026

Valued at $67.0M at its later-stage round, Aug 2024. Nothing has traded since.

Free account
More of ZBiotics with a free account
  • ·The complete investor list: 34 names
  • ·Watch ZBiotics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Valuation timeline

0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026
▮▮
Markrounds hold their value until the next priced eventMark, today
log scale
Post-money values unlock with a free account.Unlock the axis

Membership and data by Private Market View

ZBiotics funding history

2 rounds
DateRoundRaisedPost-money
Mar 2024Early Stage VC$22.4M▮
Mar 2020Early Stage VC$5.7M▮
Unlock post-money valuations

Membership and data by Private Market View

ZBiotics valuation

ZBiotics was valued at $67 million at its later-stage round in Aug 2024. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

How much has ZBiotics raised?

ZBiotics has raised $40.3 million in total; 2 of its rounds are on record. The largest on record was a $5.7 million early-stage round in Mar 2020; the most recent was a $22.4 million early-stage round in Mar 2024.

ZBiotics has filed 2 Form Ds with the SEC since 2020, most recently in Apr 2024 ($22.4 million sold to 68 investors).

How ZBiotics's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For ZBiotics, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by its last priced round. Question about this number? Full methodology →

Frequently asked about ZBiotics

What is ZBiotics worth?
ZBiotics is valued at $67.0M as of Oct 2026. Valued at $67.0M at its later-stage round, Aug 2024. Nothing has traded since.
How much has ZBiotics raised?
ZBiotics has raised $40.3M in total funding across 2 recorded rounds.
When did ZBiotics last raise?
ZBiotics last raised in Mar 2024 (Early Stage VC), raising $22.4M.